Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.30SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.30EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.30NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.5.1.30NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.5.1.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.30NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.1.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.30NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.1.30NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.1.30ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BE.11ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BE.11ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BE.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.11ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BE.11ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BE.11ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BE.11ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BE.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.11SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BE.11SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BE.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BE.11NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BE.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.11NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BE.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BE.11NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BE.11ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.5.2.9ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.5.2.9ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.5.2.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.9ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.2.9ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.2.9ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BA.5.2.9ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.5.2.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.9SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.9SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.2.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
BA.5.2.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used